2026

  1. Galdieri A, Garmo H, Gedeborg R, Ahlberg M, Orrason AW, Ventimiglia E, Stattin P, Westerberg M. Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden. Acta Oncol. 2026 Apr 15;65:282-288. Sammanfattning. Fulltext.
  2. Örtegren J, Elvstam O, Kohestani K, Kjölhede H, Styrke J, Stattin P, Berglund A, Bratt O. Number of risk factors versus infection after transrectal prostate biopsy: a nationwide population-based study. Scand J Urol. 2026 Mar 31;61:99-105. Sammanfattning. Fulltext.
  3. Ventimiglia E, Gedeborg R, Westerberg M, Zaurito P, Jäderling F, Stattin P, Garmo H. Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy results. Scand J Urol. 2026 Mar 25;61:64-71. Sammanfattning. Fulltext.
  4. Bonnedahl J, Lundström KJ, Lampa E, Robinson D, Stranne J, Carlsson S, Wagenius M, Linder A, Örtegren J, Andreasson A, Holmbom M, Stattin P, Styrke J. Risk of infectious complications after transperineal prostate biopsy compared to transrectal biopsy: nationwide population-based cohort study in Sweden. Scand J Urol. 2026 Mar 17;61:44-50. Sammanfattning. Fulltext.
  5. Zaurito P, Gedeborg R, Garmo H, Ventimiglia E, Alhberg M, Stattin P, Westerberg M. Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study. Scand J Urol. 2026 Mar 17;61:51-57. Sammanfattning. Fulltext.
  6. Ventimiglia E, Westerberg M, Zaurito P, Tiago Bonde M, Robinson D, Gedeborg R, Stattin P, Garmo H. Consequences of different definitions of disease progression in observational studies of men with advanced prostate cancer. Scand J Urol. 2026 Feb 4;61:16-22. Sammanfattning
  7. Da Silva M, Fritz J, Elhakeem A, Jochems SHJ, Sun M, Mboya IB, Häggström C, Wahlström J, Michaëlsson K, Magnusson PKE, Lagerros YT, Lönnberg L, Chabok A, Elmståhl S, Nwaru BI, Kankaanranta H, Hedman L, Backman H, Hägg S, Stattin P, Tilling K, Stocks T. Weight trajectories throughout adulthood and prostate cancer incidence, aggressiveness, and death in 258,494 men. J Natl Cancer Inst. 2026 Jan. Sammanfattning
  8. Zaurito P, Garmo H, Gedeborg R, Alhberg M, Carlsson S, Thellenberg C, Robinson D, Stattin P, Westerberg M. Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study. BJU Int. 2026 Jan 15. Sammanfattning. Fulltext.
  9. Wänman J, Farhang M, Nyström H, Styrke J, Häggström C, Stattin P, Crnalic S. Survival after spinal surgery for metastases in men with castration-sensitive vs castration-resistant prostate cancer: a nationwide register-based study. Sci Rep. 2026 Jan.Sammanfattning Fulltext